Breaking News

Medicine

USFDA pulls up Natco Pharma for manufacturing lapses at Telangana plant

Natco Pharma failed to maintain cleanliness, sterilise equipment and utensils at appropriate intervals at its Telangana-based plant, as per the US health regulator. In the warning letter to the company, US Food and Drug Administration said its investigators observed various violations at the finished pharmaceuticals plant located at Kothur Village in Telangana. The USFDA inspected…

Read More

Cipla to acquire Ivia Beaute’s cosmetics, personal care distribution and marketing biz for Rs 130 crore

Pharma major Cipla Ltd will acquire the cosmetics and personal care distribution and marketing business of Ivia Beaute Pvt Ltd, including the latter’s brands Astaberry, Ikin and Bhimsaini, on a worldwide basis for Rs 130 crore, according to a regulatory filing by the company. Cipla Health Ltd (CHL), a wholly owned subsidiary and consumer healthcare…

Read More

Cipla Q4 net profit jumps over 2-fold to Rs 357.68 cr; to raise up to Rs 6,000 cr

Drug major Cipla Wednesday reported over two-fold jump in consolidated net profit to Rs 357.68 crore for the fourth quarter ended March 31, mainly on account of robust sales across markets. The company has also decided to raise funds of up to Rs 6,000 crore. It had posted a net profit of Rs 153.25 crore…

Read More

Glenmark Pharma gets USFDA nod for cholesterol lowering drug

Glenmark Pharmaceuticals Friday said it has received final approval from the US health regulator for Ezetimibe and Simvastatin tablets, used for treating high levels of cholesterol in the blood. Citing IQVIA sales data, Glenmark said Vytorin tablets’ market achieved annual sales of approximately USD 92.4 million for the 12-month period ended April 2019. Image source:…

Read More

Aarti Drugs has a CapEx Plan of Rs 600 crore for Greenfield Projects: Adhish Patil, CFO

Adhish Patil, CFO, Aarti Drugs Ltd, talks about Q3FY21 numbers, PLI Scheme, CapEx and budget expectations during a candid chat with Swati Khandelwal, Zee Business in the run-up to the Union Budget 2021-22. Excerpts: Q: Congratulations! you have posted strong numbers for the third quarter FY21. Going forward, do you think that these numbers are sustainable?…

Read More

Exclusive: In chat with Anil Singhvi, IOL Chemicals’ Joint MD Sandeep Garg discusses Q3 results, business outlook

In today’s episode of News Par Views, Zee Business Managing Editor Anil Singhvi spoke to Sandeep Garg, Joint Managing Director (Jt MD) of IOL Chemicals. The company was started in 1986 and is a manufacturer of popular pain killer ibuprofen. It started a plant for ibuprofen in 2000 and later made a multipurpose plant. (#NewsParViews)  Garg said that the…

Read More

Dr Reddy’s Lab inks licensing pact with US-based Slayback Pharma

The company has inked a licensing pact with the NewJersey-based drug firm to acquire rights in Brimonidine Tartrate Ophthalmic Solution 0.025 percent, the Hyderabad-based firm said in a statement. As per industry estimates, the value of the total addressable market for this product in the US is around USD 130 million for the 52 weeks…

Read More

Dollar Index jumps to 5-week high: Analysts decode its impact on IT, Pharma and Apparel sector – What should investors know

For some sectors, it’s good news, and for some it’s bad, the dollar index has jumped to a five-week high on Friday to 109 level, which is the highest since July 15 in the anticipation of US Fed Reserve another rate hike and on recessionary concerns.   Export services sector such as Information and Technology as…

Read More

Sun Pharma near its 7-year high ahead of second quarter results: Buy, sell or hold? Expert suggests strategy

Sun Pharmaceuticals Industries stocks gained on Tuesday on positive July-September quarter estimates. The scrip quoted Rs 1034 apiece on NSE, up 1 per cent, in afternoon session. The drug maker also hit a fresh 52-week high of Rs 1047 today which also is the counter’s intraday high. Earlier on Monday, the counter hit a seven-year high,…

Read More

Bravo Pharma officially partners with G42 Healthcare to spearhead the field of Genomics

World-leading healthcare specialists Bravo Pharma have officially entered a strategic partnership with the region’s pioneering AI-powered healthcare company G42 Healthcare. In addition to this partnership, Bravo Pharma has also organized and participated with G42 Healthcare in a Conference dedicated to Clinical Genomics, Proteomics and Somalogic at Republicans Oncology Centre Tashkent Uzbekistan, attended by doctors from…

Read More